CRVO - CIK 0001053691
The table below shows CervoMed Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$23.45M | -$16.53M | -$7.45M | -$2.57M | -$14.50M | -$13.55M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | $18.10M | -$28.66M | $0.00 | -$12.24M | $4.00K | $0.00 |
| Dividends paid | - | - | - | - | - | - |
CervoMed Inc. reported operating cash flow of -$23.45M for fiscal year 2025. That is down 41.9% from -$16.53M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$10.77M (FY 2016) to -$23.45M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $4.59M | $46.40M | $11.15M | $0.00 | $33.30M | $17.89M |